Filed: 2/14/2025ACC: 0001493152-25-006832
📋 What this filing means
TYNDALL CAPITAL PARTNERS L P filed this quarterly 13F‑HR report disclosing 1 equity positions with a total reported market value of $530.6K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
1
Positions
$530.6K
Total AUM (reported)
164.78K
Total Shares
Allocation by class
COM$530.6K100.0%
Portfolio Concentration
Top 3$530.6K100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 164.78K
Sole
Full voting authority
164.78K
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole1
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings1
Rows:
CYCLERION THERAPEUTICS INC
SOLEShares164.78K
TypeSH
Market value$530.6K
100.00%
Sole
164.78K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CYCLERION THERAPEUTICS INCSOLE | COM | 164.78K | SH | $530.6K 100.00% | 164.78K | 0.00 | 0.00 |